Klas Malmberg
Impact in
- Endocrinology, Diabetes and Metabolism top 0.05%
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Treatment and Management
-
- Acute Myocardial Infarction Research
- Cardiovascular Function and Risk Factors
Papers in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 21
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 12
- Diabetes Treatment and Management 9
-
- Acute Myocardial Infarction Research 12
- Cardiovascular Function and Risk Factors 4
- Antiplatelet Therapy and Cardiovascular Diseases 2
- Co-authors
- Hertzel C. Gerstein (6 shared papers)Dereck Hunt (2 shared papers)Sarah E. Capes (2 shared papers)Anna Norhammar (20 shared papers)Lars Rydén (16 shared papers)Lars Rydén (41 shared papers)Hans Wedel (20 shared papers)Suad Efendić (7 shared papers)
- Journals
- European Heart Journal (14 papers)Diabetes Care (11 papers)Diabetes and Vascular Disease Research (9 papers)Journal of the American College of Cardiology (7 papers)American Heart Journal (4 papers)
- Partner nations
- SwedenCanadaUnited States
In The Last Decade
Klas Malmberg
95 papers receiving 13.6k citations
Klas Malmberg's Hit Papers
Peers
Comparison fields: 5 of 95
- Endocrinology, Diabetes and Metabolism 6.3k
- Cardiology and Cardiovascular Medicine 2.4k
- Epidemiology 668
- Pathology and Forensic Medicine 296
- Surgery 682
Countries citing papers authored by Klas Malmberg
This map shows the geographic impact of Klas Malmberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klas Malmberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klas Malmberg more than expected).
Fields of papers citing papers by Klas Malmberg
This network shows the impact of papers produced by Klas Malmberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klas Malmberg. The network helps show where Klas Malmberg may publish in the future.
Co-authors
The 25 scholars most cited alongside Klas Malmberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 96 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview Hit paper breakdown → | 2000 | 1764 |
| 2 | Stress Hyperglycemia and Prognosis of Stroke in Nondiabetic and Diabetic Patients Hit paper breakdown → | 2001 | 1459 |
| 3 | Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary Hit paper breakdown → | 2007 | 1317 |
| 4 | Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year Hit paper breakdown → | 1995 | 1202 |
| 5 | Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus Hit paper breakdown → | 1997 | 1030 |
| 6 | Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study Hit paper breakdown → | 2002 | 855 |
| 7 | Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity Hit paper breakdown → | 2005 | 798 |
| 8 | Glycometabolic State at Admission: Important Risk Marker of Mortality in Conventionally Treated Patients With Diabetes Mellitus and Acute Myocardial Infarction Hit paper breakdown → | 1999 | 671 |
| 9 | 2000 | 621 | |
| 10 | 2000 | 308 | |
| 11 | 2005 | 287 | |
| 12 | 2004 | 262 | |
| 13 | 1999 | 256 | |
| 14 | 2004 | 223 | |
| 15 | 1996 | 222 | |
| 16 | 2014 | 208 | |
| 17 | 1988 | 201 | |
| 18 | 2007 | 192 | |
| 19 | 2006 | 147 | |
| 20 | 2007 | 144 |
About Klas Malmberg
Klas Malmberg is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Surgery, Pathology and Forensic Medicine and Immunology, having authored 96 papers that have together received 15.1k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (21 papers), Acute Myocardial Infarction Research (12 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (12 papers), Diabetes Treatment and Management (9 papers), Cardiovascular Function and Risk Factors (4 papers), Coronary Interventions and Diagnostics (4 papers), Antiplatelet Therapy and Cardiovascular Diseases (2 papers) and Cardiac Ischemia and Reperfusion (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (6.3k citations), Cardiology and Cardiovascular Medicine (2.4k citations), Epidemiology (668 citations), Pathology and Forensic Medicine (296 citations) and Surgery (682 citations). Klas Malmberg has collaborated with scholars based in Sweden, Canada and United States. Frequent co-authors include Hertzel C. Gerstein, Dereck Hunt, Sarah E. Capes, Anna Norhammar, Lars Rydén, Lars Rydén, Hans Wedel, Suad Efendić, Johan D. Herlitz and Anders P. Waldenström. Their work appears in journals such as European Heart Journal, Diabetes Care, Diabetes and Vascular Disease Research, Journal of the American College of Cardiology and American Heart Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.